Litigation Details for Purdue Pharma L.P. v. Ascent Pharmaceuticals, Inc. (D. Del. 2018)

Purdue Pharma L.P. v. Ascent Pharmaceuticals, Inc. (D. Del. 2018)

Docket		Date Filed	2018-01-10
Court	District Court, D. Delaware	Date Terminated	2019-04-01
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Patents	8,309,060; 9,060,976; 9,073,933; 9,522,919; 9,675,610
Link to Docket	External link to docket

Details for Purdue Pharma L.P. v. Ascent Pharmaceuticals, Inc. (D. Del. 2018)

Date Filed	Document No.	Description	Snippet	Link To Document
2018-01-10	1		the “’919 patent”); 9,149,533 (the “’533 patent”); 9,861,582 (the “’582 patent”); 8,309,060 (the “’060…RELIEF (PATENT INFRINGEMENT OF U.S. PATENT NO. 8,309,060) 70. Grünenthal… United States Patent Nos. 9,060,976 (the “’976 patent”); 9,073,933 (the “’933 patent”); 9,522,919 (the…060 patent”); and 9,675,610 (the “’610 patent”) (collectively, “the patents-in-suit”). This action…the ’060 patent from Grünenthal, with the right to enforce the ’060 patent. The ’060 patent is listed	External link to document
2018-01-10	4		,073,933; 9,522,919; 9,149,533; 9,861,582; 8,309,060; 9,675,610. (ceg) (Entered: 01/11/2018) 11 January… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,060,976; 9,073,933…2018 1 April 2019 1:18-cv-00083 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2019-04-03	55	Patent/Trademark Report to Commissioner of Patents	,073,933; 9,522,919; 9,149,533; 9,861,582; 8,309,060; 9,675,610. (Attachments: # 1 Order)(nms) (Entered… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,060,976; 9,073,933…2018 1 April 2019 1:18-cv-00083 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document